Recent Blog Articles

Close relationships with neighbors influence cardiovascular health in Black adults

Why play? Early games build bonds and brain

5 numbers linked to ideal heart health

Rating the drugs in drug ads

Postpartum anxiety is invisible, but common and treatable

The popularity of microdosing of psychedelics: What does the science say?

Pouring from an empty cup? Three ways to refill emotionally

Is pregnancy safe for everyone?

New pediatric guidelines on obesity in children and teens

Screening tests may save lives — so when is it time to stop?

Andrew Chan, MD, MPH
Contributor
Andrew T. Chan, MD, MPH is a Professor of Medicine at Harvard Medical School (HMS), Chief of the Clinical and Translational Epidemiology Unit, and the Program Director for gastroenterology training at Massachusetts General Hospital (MGH). As a clinical gastroenterologist, Dr. Chan specializes in familial gastrointestinal cancer syndromes and cancer prevention. Dr. Chan is a leading investigator in the epidemiology of colorectal cancer and other digestive diseases, with a focus on chemoprevention with aspirin and the interaction of diet with the gut microbiome. An elected fellow of the American Society of Clinical Investigation, he currently supported by NCI, NIDDK, and the Crohn’s and Colitis Foundation for his research. He has published over 400 papers in the field of colorectal cancer and other chronic digestive diseases in leading journals, including the New England Journal of Medicine, Journal of the American Medical Association, Lancet, Science Translational Medicine, Gastroenterology and Gut. Dr Chan is a section editor for Gastroenterology, serves on the editorial board of Cancer Prevention Research and Cancer Epidemiology Biomarkers and Prevention, and is vice-chair of the Gastrointestinal Oncology Section of the AGA.
Posts by Andrew Chan, MD, MPH

Cancer
Racial disparities and early-onset colorectal cancer: A call to action

Cancer
Can I take something to prevent colorectal cancer?

Cancer